BACKGROUND AND PURPOSE: Subacute lesion growth after acute ischemic stroke is associated with worse functional outcomes. The ischemic lesion severity can be assessed with Net Water Uptake (NWU), a CT-based marker of edema. Pre-treatment NWU has been associated with worse functional outcomes; however, it remains unclear how the temporal changes in NWU influence functional outcomes. In this study, we aimed to determine how associations between NWU and functional outcome vary across imaging times up to 1 week after stroke. MATERIALS AND METHODS: We included patients from the MRCLEAN NO-IV trial with anterior circulation large vessel occlusion who were treated with endovascular treatment and had baseline, 24-hour, and 1-week follow-up non-contrast CT scans. Functional outcome at 90 days was evaluated using the modified Rankin Scale (mRS), analyzed both as functional independence (mRS 0–2) and across the full ordinal distribution (mRS 0–6). In the primary analysis, associations between NWU measured at different imaging timepoints and functional independence were examined using univariable and multivariable logistic regression models. To evaluate temporal changes in NWU, ΔNWU was calculated at different time intervals (baseline-24 hours, 24 hours-1 week, and baseline-1 week), and its association with outcomes was analyzed using analogous regression models. RESULTS: Out of 539 MRCLEAN NO-IV patients, 115 were included in this study. The median time from stroke onset to randomization was 92(70-140) minutes. The median NWU evolved from 4.3%(IQR:2.1-6.8%) at baseline to 9.0%(IQR:3.0-13%) at 24 hours and 15%(IQR:11-19%) at 1 week. The median patient-level change (ΔNWU) from baseline to 1 week was 10%(IQR: 5.3-16%). NWU measured at 1 week, but not at baseline or 24 hours, was significantly associated with functional dependence, with an aOR of 0.66(95%CI=0.47-0.90) per 5-percantage-point increase in NWU. Furthermore, a higher increase in NWU from baseline to 1 week imaging was significantly associated with functional dependence, with an aOR of 0.66(95%CI=0.47-0.86) per 5-percentage-point increase in ΔNWU1wk-BL. CONCLUSIONS: In our population, NWU measured at 1 week is associated with 90-day clinical outcomes, suggesting that lesion evolution continues in the first week after stroke onset and may therefore represent a target for secondary treatments to improve clinical outcomes.
Olszewski et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: